Creative Biolabs, a leader in the field of gene-engineered T cells for cancer therapy, offers gene packaging and delivery services for the generation of TCR-modified T cells. Relying on our advanced technologies and rich experience, we can provide the most professional TCR transfection for the most cutting-edge genetically modified immunotherapies.
T lymphocytes play a crucial role in immunity and there are various gene therapy strategies targeting T cells. The efficient gene transfer into T cells facilitates the treatment of several genetic dysfunctions, inherited diseases and acquired diseases. TCR gene transfer via cell fusion or electroporation is also shown to confer MHC restricted specificity to nonspecific T cells. However, these initial processes are generally inefficient for a great number of T cells for clinical application.
Retroviral: the advent of retroviral vectors not only makes gene transfer more efficient at large scale but also enables the stable integration of exogenous genes. Despite demonstrations of scalability and stable expression, retroviral vectors require full T-cell activation for efficient gene transduction that may, in certain culture systems, inhibit cell function.
Lentiviral: lentiviral vectors have the potential to be safer from the perspective of insertional mutagenesis and they have substantially higher transduction efficiency for genetically engineering human T cells. Recently, lentiviral vectors have emerged as a favorable vector system for stably expressing two-gene TCRs, which require dual gene expression. Bicistronic lentiviral vectors that provide for high-level tumor or viral antigen-specific TCR gene expression in T cells have been developed to show strong promise for clinical application.
Electroporation: electroporation-mediated mRNA transfection is an alternative and promising approach without many limitations associated with gene transfer vectors that insert in the genome. mRNA manufacture and delivery does not require the significant costs of manufacture and testing that exogenous viral vectors need.
Fig.1 Retroviral Gene Transfer to Generate Tumor-Specific T Cells
Creative Biolabs has the capability to enable you to free up your time for core work and project. Our service can be designed to meet your special needs if you have any requirements. If you are interested in our service, please contact us by E-mail and our team will get back to you as soon as possible.
For any technical issues or products/services related questions, please leave your information below. Our team will contact you soon.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
Angiotensin-converting Enzyme 2 (ACE2)-CHO Cell Line Model for COVID-19: Helps researchers to further study the interaction between the receptor ACE2 and the COVID-19 virus.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE